Attralus To Present Phase 1/2 Data on Its Pan Amyloid Depleter at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition Read More Nov 4, 2025
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance Read More Oct 23, 2025
Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025 Read More Jul 10, 2025
Candid Therapeutics Advances Portfolio of Novel T-Cell Engagers into Five Autoimmune Diseases for Clinical Evaluation Read More Jun 20, 2025
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation Read More Jun 5, 2025
